Innovation Works

Revitalize Energy is a consumer health company specializing in eye drops designed to combat digital eye strain. Their product uses a proprietary blend of stimulants and amino acids to provide immediate relief from eye fatigue caused by prolonged screen use.

Plexision develops cellular biomarkers and personalized diagnostic tests for immunological disorders and solid organ transplantation. Its Pleximmune blood test predicts transplant rejection by measuring antigen-specific white blood cells, supported by patent-pending technology. The company operates a CLIA-certified central laboratory in Pittsburgh providing testing services for transplant recipients and drug developers. Its platform enables assessment of disease risk, prediction of drug efficacy for individual patients, and guidance on dosing for novel immunological therapies, with capabilities including rapid six-hour panels for conditions such as CMV infection and transplant rejection, and a focus on pediatric liver and intestine transplant patients.

SignatureDx is a biotechnology company that develops and operates a bioanalytical platform. This platform is designed to detect and monitor complex human diseases in their early, silent stages. The company focuses on non-invasive diagnostic testing, aiming to predict and treat diseases before they cause significant organ damage. By specializing in novel methods, SignatureDx enables individuals to receive timely and successful treatment, thereby improving health outcomes.

Sensi Fit is a manufacturer specializing in athletic equipment, primarily developing fitness testing sensors. These sensors are designed to facilitate athletic testing for high-performance athletes, providing real-time quantitative data, biomechanics feedback, and training guidance. This enables athletes to enhance their performance without the need for wearables.

D.Sole is a healthcare technology company focused on advancing remote patient monitoring in podiatry through innovative multimodal foot insoles. These insoles are designed for the early detection and monitoring of diabetic foot complications, including ulcers and deformities. By integrating advanced machine learning algorithms, D.Sole provides clinicians with comprehensive foot physiological data, enabling evidence-based insights for targeted treatments. The company's insoles are significantly more affordable than current market options, capable of detecting 15 types of foot complications, in contrast to competitors that only identify one. D.Sole aims to reduce healthcare costs substantially, potentially saving wound clinics over $100 million annually by lowering readmission rates for foot complications. Additionally, private insurers could save over $1 billion by reducing expenses related to amputations and wound care.

Resilient Lifescience specializes in developing wearable medical devices designed to prevent opioid overdose deaths. Their innovative device detects and automatically administers naloxone, enabling timely intervention even when no one else is present.

Ilant Health specializes in managing obesity and cardiometabolic health. Its platform employs machine learning analytics to drive insights for improved patient outcomes and reduced healthcare costs.

Magnify Biosciences specializes in advanced microscopy solutions, offering a high-resolution imaging platform and associated services. Their technology physically expands biological samples, enabling researchers to study complex structures and molecular interactions at the nanoscale, beyond the typical limits of light microscopy. This empowers researchers, entrepreneurs, and diagnostic labs to gain unique insights into cellular architecture, facilitating advancements in life sciences and diagnostics.

Ariel Precision Medicine, Inc. is an integrated genomics and digital health company focused on providing precision medicine solutions for the diagnosis, monitoring, and treatment of complex chronic diseases and disorders. Founded in 2015 and headquartered in Pittsburgh, Pennsylvania, the company develops innovative clinical decision support tools aimed at simplifying personalized treatment in both emergency departments and clinical settings. One of its key offerings is ArielDx, a cloud-based tool designed to enhance the diagnosis and treatment of pancreatic disease, thereby improving patient outcomes through tailored healthcare solutions.

Revitalize Energy is a consumer health company specializing in eye drops designed to combat digital eye strain. Their product uses a proprietary blend of stimulants and amino acids to provide immediate relief from eye fatigue caused by prolonged screen use.

InnSight Technology is a biotechnology company focused on advancing the diagnostics and evaluation of eye diseases. The company specializes in developing innovative ophthalmic devices, including a novel, hand-held biosensor designed for the detection of anterior ophthalmic injuries. Additionally, InnSight Technology works on the development of nanotechnology-based medical devices aimed at addressing various clinical needs in ophthalmology. By providing these advanced tools, the company enables clinicians to enhance ocular care and improve patient outcomes in eye health.

Gus Gear is a manufacturer of wearable securement clothing designed to protect implanted medical devices and enhance patient outcomes. The company's flagship product, the Central Line Vest, safeguards central catheters from damage, breakage, and accidental removal, allowing patients to maintain their quality of life while undergoing treatment. In addition to the Central Line Vest, Gus Gear's platform offers securement solutions for various medical devices, including ostomy pouches and feeding tubes. By using innovative securement systems, Gus Gear enables patients to manage their medical challenges effectively, promoting independence and wellbeing.

PECA Labs is a Pittsburgh-based medical device company spun out of Carnegie Mellon University and UPMC that develops polymeric heart valves and vascular grafts for pediatric congenital heart disease. Its lead product, the MASA Valve, is a synthetic valved conduit intended for pediatric right ventricular outflow tract reconstruction, leveraging ePTFE material properties and radiopaque markings to improve durability and intraoperative configurability. The company also offers exGraft, an ePTFE vascular graft with radiopaque markers. PECA Labs focuses on orphan patient populations and aims to reduce the need for multiple surgeries in children, with the MASA Valve designed to address limitations of existing conduits. The MASA Valve has received FDA Humanitarian Use Device designation, and early intraoperative implants have demonstrated reduced re-operation rates compared with alternatives. Headquartered in Pittsburgh since its founding around 2011-2012, PECA Labs pursues pediatric cardiovascular solutions with an emphasis on improving long-term outcomes for congenital heart disease patients.

MindTrace is a medical software company specializing in the development of personalized 3D brain maps to enhance neurosurgical procedures. By integrating machine learning algorithms with advanced brain imaging and cloud-based computing, MindTrace creates clinical decision support tools that allow neurosurgeons to simulate surgical resection plans. This innovative approach enables surgeons to predict patients' cognitive outcomes prior to surgery, facilitating the removal of brain tumors while minimizing damage to surrounding healthy tissue. MindTrace's technology aims to streamline the workflow of neurosurgical teams by reducing the time spent on testing and analyzing complex brain imaging and behavioral data sets, ultimately improving patient care in the field of neurosurgery.

Revitalize Energy is a consumer health company specializing in eye drops designed to combat digital eye strain. Their product uses a proprietary blend of stimulants and amino acids to provide immediate relief from eye fatigue caused by prolonged screen use.

Hava Health, Inc. is a biotechnology company based in the United States that specializes in developing innovative solutions for nicotine addiction. The company manufactures a smoking cessation device, which includes a connected vape pen that integrates with a smartphone application called Hale. This digital drug therapy device aims to support individuals in their efforts to quit smoking by providing a modern approach to nicotine de-addiction. Through its technology, Hava Health seeks to enhance the effectiveness of smoking cessation efforts and improve health outcomes for users.

MindTrace is a medical software company specializing in the development of personalized 3D brain maps to enhance neurosurgical procedures. By integrating machine learning algorithms with advanced brain imaging and cloud-based computing, MindTrace creates clinical decision support tools that allow neurosurgeons to simulate surgical resection plans. This innovative approach enables surgeons to predict patients' cognitive outcomes prior to surgery, facilitating the removal of brain tumors while minimizing damage to surrounding healthy tissue. MindTrace's technology aims to streamline the workflow of neurosurgical teams by reducing the time spent on testing and analyzing complex brain imaging and behavioral data sets, ultimately improving patient care in the field of neurosurgery.

PECA Labs is a Pittsburgh-based medical device company spun out of Carnegie Mellon University and UPMC that develops polymeric heart valves and vascular grafts for pediatric congenital heart disease. Its lead product, the MASA Valve, is a synthetic valved conduit intended for pediatric right ventricular outflow tract reconstruction, leveraging ePTFE material properties and radiopaque markings to improve durability and intraoperative configurability. The company also offers exGraft, an ePTFE vascular graft with radiopaque markers. PECA Labs focuses on orphan patient populations and aims to reduce the need for multiple surgeries in children, with the MASA Valve designed to address limitations of existing conduits. The MASA Valve has received FDA Humanitarian Use Device designation, and early intraoperative implants have demonstrated reduced re-operation rates compared with alternatives. Headquartered in Pittsburgh since its founding around 2011-2012, PECA Labs pursues pediatric cardiovascular solutions with an emphasis on improving long-term outcomes for congenital heart disease patients.

Endolumik develops visualization-enhanced devices for minimally invasive surgery, applying fluorescence-guided near-infrared technology to improve intraoperative visibility, safety, and precision. Its portfolio includes a near-infrared gastric calibration tube and additional illumination technologies, supported by proprietary IP. The company targets bariatric, general, and colorectal procedures to enable surgeons to better see anatomy and instruments during operations, with the aim of improving surgical outcomes. Endolumik is headquartered in Morgantown, United States.

Ariel Precision Medicine, Inc. is an integrated genomics and digital health company focused on providing precision medicine solutions for the diagnosis, monitoring, and treatment of complex chronic diseases and disorders. Founded in 2015 and headquartered in Pittsburgh, Pennsylvania, the company develops innovative clinical decision support tools aimed at simplifying personalized treatment in both emergency departments and clinical settings. One of its key offerings is ArielDx, a cloud-based tool designed to enhance the diagnosis and treatment of pancreatic disease, thereby improving patient outcomes through tailored healthcare solutions.

Gus Gear is a manufacturer of wearable securement clothing designed to protect implanted medical devices and enhance patient outcomes. The company's flagship product, the Central Line Vest, safeguards central catheters from damage, breakage, and accidental removal, allowing patients to maintain their quality of life while undergoing treatment. In addition to the Central Line Vest, Gus Gear's platform offers securement solutions for various medical devices, including ostomy pouches and feeding tubes. By using innovative securement systems, Gus Gear enables patients to manage their medical challenges effectively, promoting independence and wellbeing.

SovaSage is a digital healthcare platform used to come up with the treatment of sleep apnea patients and other chronic conditions. It was founded in 2020 and is headquartered in Pittsburgh, Pennsylvania.

SwifTAG Systems concepts and products were conceived by active researchers in the medical field who recognized the dramatic inefficiencies of existing small animal management systems and processes. Their mission is to bring high technology and medical research together to drive down costs and increase the time researchers spend doing actual research. They envision laboratories where animal management systems are functional, low maintenance, efficient, and as easy to use as a well-designed smartphone app. They want to see researchers focusing on medical breakthroughs, not on mindless small animal logistics. Their product lines include small animal tags, handheld and tabletop readers, cage and rack readers, whole laboratory management systems, and support software.

Ariel Precision Medicine, Inc. is an integrated genomics and digital health company focused on providing precision medicine solutions for the diagnosis, monitoring, and treatment of complex chronic diseases and disorders. Founded in 2015 and headquartered in Pittsburgh, Pennsylvania, the company develops innovative clinical decision support tools aimed at simplifying personalized treatment in both emergency departments and clinical settings. One of its key offerings is ArielDx, a cloud-based tool designed to enhance the diagnosis and treatment of pancreatic disease, thereby improving patient outcomes through tailored healthcare solutions.

Gus Gear is a manufacturer of wearable securement clothing designed to protect implanted medical devices and enhance patient outcomes. The company's flagship product, the Central Line Vest, safeguards central catheters from damage, breakage, and accidental removal, allowing patients to maintain their quality of life while undergoing treatment. In addition to the Central Line Vest, Gus Gear's platform offers securement solutions for various medical devices, including ostomy pouches and feeding tubes. By using innovative securement systems, Gus Gear enables patients to manage their medical challenges effectively, promoting independence and wellbeing.

Cassian Solutions, Inc. is a company based in Phoenixville, Pennsylvania, that specializes in developing innovative medication management solutions. Founded in 2018, it designs and manufactures a unique phone case medication dispenser alongside a comprehensive application that enhances patient adherence to prescribed treatments. The app features tools for outcome collection, biometric verification, medication reminders, adherence verification, environmental sensing, treatment analysis, real-time communication, and medication distribution. Cassian Solutions serves a diverse clientele, including pharmacies, clinical trial companies, drug manufacturers, and insurers. By addressing critical gaps in patient monitoring and data reporting, the company aims to improve health outcomes and streamline the pharmaceutical value chain, ultimately enhancing the medication experience for patients and healthcare providers alike.

SwifTAG Systems concepts and products were conceived by active researchers in the medical field who recognized the dramatic inefficiencies of existing small animal management systems and processes. Their mission is to bring high technology and medical research together to drive down costs and increase the time researchers spend doing actual research. They envision laboratories where animal management systems are functional, low maintenance, efficient, and as easy to use as a well-designed smartphone app. They want to see researchers focusing on medical breakthroughs, not on mindless small animal logistics. Their product lines include small animal tags, handheld and tabletop readers, cage and rack readers, whole laboratory management systems, and support software.

Ariel Precision Medicine, Inc. is an integrated genomics and digital health company focused on providing precision medicine solutions for the diagnosis, monitoring, and treatment of complex chronic diseases and disorders. Founded in 2015 and headquartered in Pittsburgh, Pennsylvania, the company develops innovative clinical decision support tools aimed at simplifying personalized treatment in both emergency departments and clinical settings. One of its key offerings is ArielDx, a cloud-based tool designed to enhance the diagnosis and treatment of pancreatic disease, thereby improving patient outcomes through tailored healthcare solutions.

Cassian Solutions, Inc. is a company based in Phoenixville, Pennsylvania, that specializes in developing innovative medication management solutions. Founded in 2018, it designs and manufactures a unique phone case medication dispenser alongside a comprehensive application that enhances patient adherence to prescribed treatments. The app features tools for outcome collection, biometric verification, medication reminders, adherence verification, environmental sensing, treatment analysis, real-time communication, and medication distribution. Cassian Solutions serves a diverse clientele, including pharmacies, clinical trial companies, drug manufacturers, and insurers. By addressing critical gaps in patient monitoring and data reporting, the company aims to improve health outcomes and streamline the pharmaceutical value chain, ultimately enhancing the medication experience for patients and healthcare providers alike.

PECA Labs is a Pittsburgh-based medical device company spun out of Carnegie Mellon University and UPMC that develops polymeric heart valves and vascular grafts for pediatric congenital heart disease. Its lead product, the MASA Valve, is a synthetic valved conduit intended for pediatric right ventricular outflow tract reconstruction, leveraging ePTFE material properties and radiopaque markings to improve durability and intraoperative configurability. The company also offers exGraft, an ePTFE vascular graft with radiopaque markers. PECA Labs focuses on orphan patient populations and aims to reduce the need for multiple surgeries in children, with the MASA Valve designed to address limitations of existing conduits. The MASA Valve has received FDA Humanitarian Use Device designation, and early intraoperative implants have demonstrated reduced re-operation rates compared with alternatives. Headquartered in Pittsburgh since its founding around 2011-2012, PECA Labs pursues pediatric cardiovascular solutions with an emphasis on improving long-term outcomes for congenital heart disease patients.

Ariel Precision Medicine, Inc. is an integrated genomics and digital health company focused on providing precision medicine solutions for the diagnosis, monitoring, and treatment of complex chronic diseases and disorders. Founded in 2015 and headquartered in Pittsburgh, Pennsylvania, the company develops innovative clinical decision support tools aimed at simplifying personalized treatment in both emergency departments and clinical settings. One of its key offerings is ArielDx, a cloud-based tool designed to enhance the diagnosis and treatment of pancreatic disease, thereby improving patient outcomes through tailored healthcare solutions.

Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior integrates wearable devices with machine learning algorithms to analyze real-time data from various physiological metrics, such as heart rate and skin temperature. The company’s platform, known as Recovery, employs this data to deliver timely interventions tailored to the needs of individuals in recovery. By utilizing a SaaS business model, Behaivior aims to democratize mental health recovery and support, assisting users in maintaining their wellness while enabling care providers to enhance their service delivery. Through its proactive approach, Behaivior seeks to improve mental health outcomes and reduce crisis events associated with addiction.

Sharp Edge Labs, Inc. is a biotechnology company based in Pittsburgh, Pennsylvania, specializing in the development of biosensors for drug discovery and cellular biology research. The company creates Fluorogenic Activating Modules (FAMs) that enable accurate detection of cellular trafficking, facilitating high-throughput screening and subsequent analysis. Its offerings include single-chain antibody fragments that activate fluorescence in specially designed dyes, assays for receptor internalization, and fluorogenic sensor dyes. Sharp Edge Labs focuses on addressing monogenic diseases, trafficking defects, and patient-driven discovery, with specific programs aimed at correcting trafficking defects in conditions such as cystic fibrosis and Parkinson's disease, as well as addressing lysosomal storage disorders. Originally known as Sharp Edge Technologies, Inc., the company was incorporated in 2010.

Founded in 2013, ThoroughCare specializes in web-based software solutions designed to manage Medicare's preventive programs. Its offerings include tools for chronic care management, annual wellness visits, and patient assessments, aiming to improve the quality of life for patients while increasing engagement with healthcare providers.

Ariel Precision Medicine, Inc. is an integrated genomics and digital health company focused on providing precision medicine solutions for the diagnosis, monitoring, and treatment of complex chronic diseases and disorders. Founded in 2015 and headquartered in Pittsburgh, Pennsylvania, the company develops innovative clinical decision support tools aimed at simplifying personalized treatment in both emergency departments and clinical settings. One of its key offerings is ArielDx, a cloud-based tool designed to enhance the diagnosis and treatment of pancreatic disease, thereby improving patient outcomes through tailored healthcare solutions.

PECA Labs is a Pittsburgh-based medical device company spun out of Carnegie Mellon University and UPMC that develops polymeric heart valves and vascular grafts for pediatric congenital heart disease. Its lead product, the MASA Valve, is a synthetic valved conduit intended for pediatric right ventricular outflow tract reconstruction, leveraging ePTFE material properties and radiopaque markings to improve durability and intraoperative configurability. The company also offers exGraft, an ePTFE vascular graft with radiopaque markers. PECA Labs focuses on orphan patient populations and aims to reduce the need for multiple surgeries in children, with the MASA Valve designed to address limitations of existing conduits. The MASA Valve has received FDA Humanitarian Use Device designation, and early intraoperative implants have demonstrated reduced re-operation rates compared with alternatives. Headquartered in Pittsburgh since its founding around 2011-2012, PECA Labs pursues pediatric cardiovascular solutions with an emphasis on improving long-term outcomes for congenital heart disease patients.

Sharp Edge Labs, Inc. is a biotechnology company based in Pittsburgh, Pennsylvania, specializing in the development of biosensors for drug discovery and cellular biology research. The company creates Fluorogenic Activating Modules (FAMs) that enable accurate detection of cellular trafficking, facilitating high-throughput screening and subsequent analysis. Its offerings include single-chain antibody fragments that activate fluorescence in specially designed dyes, assays for receptor internalization, and fluorogenic sensor dyes. Sharp Edge Labs focuses on addressing monogenic diseases, trafficking defects, and patient-driven discovery, with specific programs aimed at correcting trafficking defects in conditions such as cystic fibrosis and Parkinson's disease, as well as addressing lysosomal storage disorders. Originally known as Sharp Edge Technologies, Inc., the company was incorporated in 2010.

Pratter is a healthcare technology company that provides a medical cost savings platform designed to enhance price transparency in healthcare services. The platform allows users to access and compare prices for over 600 outpatient cost items, including blood work, imaging studies like MRIs and CTs, and elective medical procedures such as colonoscopies and cataract surgeries. By enabling individuals to look up prices based on their zip codes, Pratter empowers users to make informed decisions about their healthcare costs and find affordable options from various providers. The service is offered as an employee benefit, aiming to facilitate access to routine medical care while reducing overall medical expenses.

Accel Diagnostics, LLC is a medical diagnostics company based in Pittsburgh, Pennsylvania, founded in 2008. The company develops innovative diagnostic technologies, including the pScreen Card, a disposable, credit-card-sized blood diagnostic platform that detects and quantifies biomarkers through a companion mobile application. This lab-on-chip technology allows for rapid diagnosis of infectious and chronic diseases at the point-of-care, delivering accurate results within 30 minutes and enhancing the quality of care while reducing costs. Additionally, Accel Diagnostics focuses on heart failure management, enabling patients to monitor their condition at home and allowing timely responses to heart distress before severe symptoms arise. This approach aims to reduce life-threatening events and prevent costly hospitalizations, representing a significant advancement in patient care for congestive heart failure.

Accel Diagnostics, LLC is a medical diagnostics company based in Pittsburgh, Pennsylvania, founded in 2008. The company develops innovative diagnostic technologies, including the pScreen Card, a disposable, credit-card-sized blood diagnostic platform that detects and quantifies biomarkers through a companion mobile application. This lab-on-chip technology allows for rapid diagnosis of infectious and chronic diseases at the point-of-care, delivering accurate results within 30 minutes and enhancing the quality of care while reducing costs. Additionally, Accel Diagnostics focuses on heart failure management, enabling patients to monitor their condition at home and allowing timely responses to heart distress before severe symptoms arise. This approach aims to reduce life-threatening events and prevent costly hospitalizations, representing a significant advancement in patient care for congestive heart failure.

Adaptics Ltd. provides Drop, an iPad-connected kitchen scale and digital baking assistant for home bakers. Adaptics adds noticeable vitality to employees and organisations and helps them maintain long-term success. They do this by embedding top-quality service provision in vitalising managers, teams and players. Adaptics considers vitality a strategic resource that forms a basis for desired change in society. They have developed a unique integral approach that includes training, coaching, instructions and online tools. Adaptics has the ambition to address vitality at Champions League level, and to set the standard for corporate health in the Netherlands along with its partners and clients.

Sharp Edge Labs, Inc. is a biotechnology company based in Pittsburgh, Pennsylvania, specializing in the development of biosensors for drug discovery and cellular biology research. The company creates Fluorogenic Activating Modules (FAMs) that enable accurate detection of cellular trafficking, facilitating high-throughput screening and subsequent analysis. Its offerings include single-chain antibody fragments that activate fluorescence in specially designed dyes, assays for receptor internalization, and fluorogenic sensor dyes. Sharp Edge Labs focuses on addressing monogenic diseases, trafficking defects, and patient-driven discovery, with specific programs aimed at correcting trafficking defects in conditions such as cystic fibrosis and Parkinson's disease, as well as addressing lysosomal storage disorders. Originally known as Sharp Edge Technologies, Inc., the company was incorporated in 2010.

NanoVision Diagnostics, Inc. is a company focused on the development and commercialization of innovative optical biomarkers for cancer detection. Founded in 2013 and based in Kittanning, Pennsylvania, the company has created a novel electro-optical cancer diagnostic system that analyzes standard biopsy slides. This system identifies molecular changes in nuclear structure that traditional pathology may overlook, allowing for the early detection and treatment of cancer. By leveraging advanced optical analysis, NanoVision Diagnostics aims to improve cancer diagnosis and enhance patient outcomes through its cutting-edge technologies.

PECA Labs is a Pittsburgh-based medical device company spun out of Carnegie Mellon University and UPMC that develops polymeric heart valves and vascular grafts for pediatric congenital heart disease. Its lead product, the MASA Valve, is a synthetic valved conduit intended for pediatric right ventricular outflow tract reconstruction, leveraging ePTFE material properties and radiopaque markings to improve durability and intraoperative configurability. The company also offers exGraft, an ePTFE vascular graft with radiopaque markers. PECA Labs focuses on orphan patient populations and aims to reduce the need for multiple surgeries in children, with the MASA Valve designed to address limitations of existing conduits. The MASA Valve has received FDA Humanitarian Use Device designation, and early intraoperative implants have demonstrated reduced re-operation rates compared with alternatives. Headquartered in Pittsburgh since its founding around 2011-2012, PECA Labs pursues pediatric cardiovascular solutions with an emphasis on improving long-term outcomes for congenital heart disease patients.

Accel Diagnostics, LLC is a medical diagnostics company based in Pittsburgh, Pennsylvania, founded in 2008. The company develops innovative diagnostic technologies, including the pScreen Card, a disposable, credit-card-sized blood diagnostic platform that detects and quantifies biomarkers through a companion mobile application. This lab-on-chip technology allows for rapid diagnosis of infectious and chronic diseases at the point-of-care, delivering accurate results within 30 minutes and enhancing the quality of care while reducing costs. Additionally, Accel Diagnostics focuses on heart failure management, enabling patients to monitor their condition at home and allowing timely responses to heart distress before severe symptoms arise. This approach aims to reduce life-threatening events and prevent costly hospitalizations, representing a significant advancement in patient care for congestive heart failure.

Mobile Aspects is a Pittsburgh, Pennsylvania based healthcare software company that provides surgical documentation and perioperative workflow solutions. Its platform offers data analytics, endoscope tracking, supply and implant tracking, tissue tracking, and smart cabinet solutions to improve patient safety and operating room efficiency. The software helps hospitals and academic medical centers streamline documentation, enhance traceability of instruments and implants, and optimize perioperative workflows. Mobile Aspects’ solutions are deployed across a broad range of hospitals in the United States and internationally, including leading institutions recognized for safety and quality. By integrating documentation with tracking and analytics, the company aims to support improved care delivery and hospital profitability.